Neurological Manifestations of Coronavirus Disease 2019

Samuel F. Huth, Sung-Min Cho, Chiara Robba, David Highton, Denise Battaglini, Judith Bellapart, Jacky Y. Suen, Gianluigi Li Bassi, Fabio Silvio Taccone, Rakesh C. Arora, Glenn Whitman, John Fraser, Jonathon P. Fanning. https://doi.org/10.3389/fneur.2021.664599

Background: There is growing evidence that SARS-Cov-2 infection is associated with severe neurological complications. Understanding the nature and prevalence of these neurologic manifestations is essential for identifying higher-risk patients and projecting demand for ongoing resource utilisation. This review and meta-analysis report the neurologic manifestations identified in hospitalised COVID-19 patients and provide a preliminary estimate of disease prevalence. Methods: MEDLINE, Embase and Scopus were searched for studies reporting the occurrence of neurological complications in hospitalised COVID-19 patients.

Previous
Previous

Ethical factors determining ECMO allocation

Next
Next

An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients